Agenda

Session Introduction

‍

ADCs for Metastatic TNBC: Comparative Efficacy and Safety and Sequencing

‍

Novel ADCs for Metastatic TNBC

‍

Management and Prevention of Triple Negative CNS Metastases

‍

Who are the Metastatic TNBC Exceptional Responders?

‍

Audience Q&A and Panel Discussion